{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:06:23Z","timestamp":1760187983515},"reference-count":18,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2000,6,1]],"date-time":"2000-06-01T00:00:00Z","timestamp":959817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T00:00:00Z","timestamp":1577145600000},"content-version":"vor","delay-in-days":7145,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2000,6]]},"DOI":"10.1023\/a:1008349300781","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T14:41:38Z","timestamp":1040568098000},"page":"735-741","source":"Crossref","is-referenced-by-count":33,"title":["Phase I open study of the effects of ascending doses of the cytotoxic immunoconjugate CMB-401 (hCTMO1-calicheamicin) in patients with epithelial ovarian cancer"],"prefix":"10.1016","volume":"11","author":[{"given":"A.M.","family":"Gillespie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.J.","family":"Broadhead","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.Y.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Owen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.P.","family":"Farnsworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Sopwith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.E.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1023\/A:1008349300781_bb0005","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/ijc.2910540413","article-title":"Estimates of the worldwide incidence of eighteen major cancers in 1985","volume":"54","author":"Parkin","year":"1993","journal-title":"Int J Cancer"},{"key":"10.1023\/A:1008349300781_bb0010","series-title":"Gynaecology","first-page":"519","article-title":"Carcinoma of the ovary and fallopian tube","author":"Anderson","year":"1992"},{"key":"10.1023\/A:1008349300781_bb0015","series-title":"Survival of Cancer Patients in Europe: A EUROCARE Study","first-page":"292","author":"Berrino","year":"1995"},{"key":"10.1023\/A:1008349300781_bb0020","series-title":"OPCS series DHZ, No. 18","article-title":"Mortality Statistics: Cause (England and Wales) 1991","year":"1993"},{"key":"10.1023\/A:1008349300781_bb0025","first-page":"55","article-title":"Tissue and tumor distribution of human polymorphic epithelial mucin","volume":"11-12","author":"Zotter","year":"1988","journal-title":"Cancer Res"},{"issue":"26","key":"10.1023\/A:1008349300781_bb0030","doi-asserted-by":"crossref","first-page":"12820","DOI":"10.1016\/S0021-9258(18)37632-4","article-title":"A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomasis made up of tandem repeats","volume":"263","author":"Gendler","year":"1988","journal-title":"J Biol Chem"},{"issue":"25","key":"10.1023\/A:1008349300781_bb0035","doi-asserted-by":"crossref","first-page":"15286","DOI":"10.1016\/S0021-9258(18)77254-2","article-title":"Molecular cloning and expression of the human tumour-associated polymorphic epithelial mucin","volume":"265","author":"Gendler","year":"1990","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1023\/A:1008349300781_bb0040","first-page":"872","article-title":"Structure of neutral O-linked polylactosaminoglycans on human skim milk mucins. A novel type of linearly extended poly-N-acetyl-lactosamine backbones with Gal\u03b2(1\u20134) GlcNAcp(1-6) repeating units","volume":"264","author":"Hanish","year":"1989","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1023\/A:1008349300781_bb0045","first-page":"261","article-title":"Oligosaccharide differences in the DF3 sialomucin antigen from normal human milk and the BT-20 human breast carcinoma cell line","volume":"1","author":"Hull","year":"1989","journal-title":"Cancer Commun"},{"key":"10.1023\/A:1008349300781_bb0050","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S0140-6736(94)92398-1","article-title":"Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group","volume":"343","author":"Reithmiiller","year":"1994","journal-title":"Lancet"},{"key":"10.1023\/A:1008349300781_bb0055","first-page":"3188","article-title":"Binding and endocytosis of a monoclonal antibody to a high molecular weight human milk fat globule membrane-associated antigen by cultured MCF-7 breast cancer cells","volume":"48","author":"Aboud-Pirak","year":"1988","journal-title":"Cancer Res"},{"key":"10.1023\/A:1008349300781_bb0060","series-title":"Antigen and Antibody Molecular Engineering in Breast Cancer Diagnosis and Treatment","first-page":"61","article-title":"Humanization of an anti-mucin antibody for breast and ovarian cancer therapy","author":"Baker","year":"1994"},{"issue":"22","key":"10.1023\/A:1008349300781_bb0065","first-page":"5179","article-title":"Biodistribution of 111indium labelled engineered human antibody CTM01 in ovarian cancer patients: Influence of protein dose","volume":"56","author":"van Hof","year":"1996","journal-title":"Cancer Res"},{"issue":"14","key":"10.1023\/A:1008349300781_bb0070","first-page":"3336","article-title":"Preparation and characterisation of monoclonal antibody conjugates of the calicheamicins: A novel and potent family of antitumour antibiotics","volume":"53","author":"Hinman","year":"1993","journal-title":"Cancer Res"},{"key":"10.1023\/A:1008349300781_bb0075","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1126\/science.3240341","article-title":"Calicheamicin yl\/1: An antitumour antibiotic that cleaves double-stranded DNA site specifically","volume":"240","author":"Zein","year":"1988","journal-title":"Science"},{"key":"10.1023\/A:1008349300781_bb0080","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1126\/science.2717946","article-title":"Calicheamicin-yl\/1 and DNA: Molecular recognition process responsible for site-specificity","volume":"244","author":"Zein","year":"1989","journal-title":"Science"},{"key":"10.1023\/A:1008349300781_bb0085","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s002620050502","article-title":"Biodistribution of 111in-labelled engineered human antibody CTM01 (hCTMOl) in ovarian cancer patients: Influence of prior administration of unlabelled hCTMOl","volume":"47","author":"Prinssen","year":"1998","journal-title":"Cancer Immunol Immunother"},{"key":"10.1023\/A:1008349300781_bb0090","series-title":"Epithelial Cancer of the Ovary","first-page":"220","article-title":"Immunology and immunotherapy of ovarian cancer","author":"Berek","year":"1995"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419552516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419552516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/11\/6\/735\/19478571\/11-6-735.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T12:32:28Z","timestamp":1621081948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419552516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,6]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2000,6]]}},"alternative-id":["S0923753419552516"],"URL":"https:\/\/doi.org\/10.1023\/a:1008349300781","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2000,6]]}}}